BioSpace News Archive

Asia

China

May 23, 2024
Australia

May 23, 2024
Sponsored

May 23, 2024
Africa

May 23, 2024
Business

Takeda Joins Hot Molecular Glue Market With $1.2B Deal

Riding the growing wave of interest in molecular glue degraders, Takeda has partnered with Chinese biotech Degron Therapeutics to develop novel therapies for oncology, neuroscience and inflammation.

May 23, 2024
·
2 min read
·
Tristan Manalac
Drug Development

Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche

Tango Therapeutics reported Thursday that solid tumor patients who stayed in the Phase I study for more than eight weeks developed Grade 3 and 4 liver function abnormalities.

May 23, 2024
·
2 min read
·
Nick Paul Taylor
Policy

FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm

In advance of Friday’s Endocrinologic and Metabolic Drugs Advisory Committee meeting, the FDA has raised concerns about hypoglycemia linked to Novo Nordisk’s insulin icodec, according to a briefing document.

May 23, 2024
·
2 min read
·
Tristan Manalac
Business

Pfizer Targets Another $1.5B in Cost Cuts By End of 2027

Amid its ongoing efforts to trim $4 billion in spending in 2024, Pfizer in an SEC filing on Wednesday said it is looking to save an additional $1.5 billion over the next several years.

May 23, 2024
·
2 min read
·
Tristan Manalac
Policy

Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program

An appellate court ruled on Tuesday that pharmaceutical companies can lawfully impose restrictions on covered drugs under the 340B Drug Pricing Program.

May 23, 2024
·
2 min read
·
Tristan Manalac
Deals

Orna Buys Competing RNA Biotech ReNAgade After Series A Financing

Orna Therapeutics announced Thursday it is acquiring ReNAgade Therapeutics, which launched in May 2023 with $300 million in Series A financing and is on BioSpace’s NextGen Class of 2024 startups to watch this year.

May 23, 2024
·
2 min read
·
Tyler Patchen